Navigation Links
Contract Pharma Hosts 13th Annual Contracting & Outsourcing Conference
Date:8/6/2014

RAMSEY, N.J., Aug. 6, 2014 /PRNewswire/ -- Contract Pharma Magazine will host the 13th annual Contracting & Outsourcing Conference & Exhibition on Sept. 18-19, 2014 at the Hyatt Regency in New Brunswick, NJ. The event will feature speakers from FDA, large and small pharma and biopharma, and industry experts, with discussion of critical issues in outsourcing, including the Pfizer Keynote on Global Pharma Outsourcing Industry Trends and the Executive Outsourcing Summit.

Contracting & Outsourcing also features a one-day tabletop exhibition on Sept. 18, with 160 exhibitors from across the pharma and biopharma contract services spectrum. In addition, an end-of-day Networking Reception sponsored by Catalent Pharma Solutions enables attendees and exhibitors to mix and mingle outside of the exhibit hall.

Conference speakers include:

  • Sunil S. Ghogre, Senior Director/Team Lead – Operational Excellence,
    External Supply – Operating Unit, Pfizer Global Supply
  • FDA Keynote: tbd, CDER/FDA
  • Jim Miller, president, PharmSource
  • Kevin Siver, Ph.D., Senior Director, Quality Operations, Onyx
  • Mary Jo Lamberti, Ph.D., Senior Research Fellow, Tufts Center for the Study of Drug Development
  • Inigo Pfeiffer, Ph.D., Senior Staff Scientist, Pharmaceutical Development Group, Targacept, Inc.
  • Mark M. Yacura, shareholder at Buchanan Ingersoll & Rooney

"Contracting & Outsourcing continues to be among the most popular and admired conferences for pharmaceutical outsourcing services in the industry today," said Kristin Brooks, Associate Editor, Contract Pharma. "The ideal environment promotes friendly and casual discussions among sponsors and contract service providers throughout the event. Additionally, the conference sessions offer attendees valuable insight into the latest industry topics on best practices and regulatory trends, with speakers representing Pfizer, Amgen, Targacept, Tufts, and FDA, and more."     

The $395 attendee fee covers all conference sessions, the exhibit hall, the reception, and in-show meals and refreshment breaks. Prize giveaways at the end of day 1 are open to all attendees.

Contract Pharma's Contracting & Outsourcing Conference & Tabletop Exhibition is the industry's premier pharma and biopharma outsourcing event, annually drawing 400 decision-making attendees and 160 contract service providers for the conference and exhibition. Visit conference.contractpharma.com for more information, including a list of exhibitors, speaker bios, and event schedule.

Contract Pharma is the leading magazine covering the market for pharma and biopharma contract services and outsourcing. Celebrating its 15th anniversary in 2014, Contract Pharma has 20,000 subscribers worldwide, while its online presence, contractpharma.com, has 38,500 monthly visitors.

Media Contact: Kristin Brooks, Contract Pharma, 201-880-2226, kbrooks@rodmanmedia.com


'/>"/>
SOURCE Contract Pharma
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Wyle Wins NASAs Fully Integrated Lifecycle Mission Support Services Contract
2. U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract
3. ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria
4. National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS
5. Pfenex Awarded Contract For Development Of Next Generation rPA-Based Anthrax Vaccine
6. CNTS Awarded $40 Million Contract Supporting U.S. Military Through Global Public Health
7. ITRA Global’s Detroit Affiliate Awarded Contract to Manage Real Estate for Michigan’s Western and Southeastern Regions
8. New In-Depth Report on Demand and Supply for Contract Manufacturing of Injectable Drugs Through 2019
9. National Institute on Drug Abuse Awards SRI International Contract to Test Safety of Medications for Treatment of Substance Abuse
10. BioProcessing Solutions Alliance Wins Million Veteran Program Genotyping Contract
11. Pfenex Inc. Awards Paragon Bioservices a Contract for cGMP Manufacturing of its Recombinant Protective Antigen (rPA), for Phase 1 Clinical Trial of its Anthrax Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Irvine, ca (PRWEB) , ... October 12, 2017 ... ... for the Surgical Wound Market with the addition of its newest module, US ... the $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... 2017  VMS BioMarketing, a leading provider of patient support ... Nurse Educator (CNE) network, which will launch this week. The ... health care professionals to enhance the patient care experience by ... other health care professionals to help women who have been ... ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
Breaking Biology News(10 mins):